β thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 64, Issue 3, 2005, Pages 484-486

  Kowal Bielecka, Otylia ^a   Kowal, K ^a   Lewszuk, A ^a   Bodzenta Lukaszyk, A ^a   Walecki, J ^a   Sierakowski, S ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; BRONCHOSCOPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; MALE; MICROVASCULATURE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS; THROMBOCYTE ACTIVATION;

ADULT; BETA-THROMBOGLOBULIN; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET FACTOR 4; SCLERODERMA, SYSTEMIC;

EID: 14144253440     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.022970     Document Type: Article

References (15)

1. Silver RM. Scleroderma. Clinical problems. The lungs. Rheum Dis Clin North Am 1996;22:825-40.
2. Steen VD, Conte C, Owens GR, Medsger TA. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994;37:1283-9.
3. Mannaiani PF, Di Bello MG, Masini E. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997;46:4-18.
4. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001;12:261-73.
5. Flavahan NA, Flavahan S, Mitra S, Chotani MA. The vasculopathy of Raynaud's phenomenon and scleroderma. Rheum Dis Clin North Am 2003;29:275-91.
6. Subcommittee for Scleroderma Criteria. American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
7. Kowal-Bielecka O, Distler O, Kowal K, Siergiejko Z, Chwiecko J, Sulik A, et al. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease. Arthritis Rheum 2003;48:1639-46.
8. Musial J, Niewiarowski S, Edmunds LH, Addonizio VP, Nicolaou KC, Colman RW. In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macao mulatto). Blood 1980;56:596-603.
9. Idell S, Maunder R, Fein AM, Switalska H, Tuszynski GP, McLarty J, et al. Platelet-specific α-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome. Chest 1989;96:1125-32.
10. Piguet PF, Vesin C. Pulmonary platelet trapping induced by bleomycin: correlation with fibrosis and involvement of the beta 2 integrins. Int J Exp Pathol 1994;75:321-8.
11. Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 2003;167:438-43.
12. Evangelista V, Celardo A, Dell'Elba G, Manarini S, Mironov A, de Gaetano G, et al. Platelet contribution to leukotriene production in inflammation: In vivo evidence in the rabbit. Thromb Haemost 1999;81:442-8.
13. Senior RM, Griffin GL, Huang JS, Walz D, Deuel T. Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol 1983;96:382-5.
14. Kamp DW. Idiopathic pulmonary fibrosis. The inflammation hypothesis revisited. Chest 2003;124:1187-90.
15. Keerthisingam CB, Jenkins RG, Harrison NK, Hernandez-Rodriguez NA, Booth H, Laurent GJ, et al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001;158:1411-22.